Breast cancer
Results
Phase 3
This trial compared 2 weekly with 3 weekly epirubicin followed by either CMF or capecitabine, after surgery for breast cancer.
Cancer Research UK supported this trial.
Recruitment start: 16 December 2005
Recruitment end: 5 December 2008
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor David Cameron
Roche
Cancer Research UK
Amgen
NIHR Clinical Research Network: Cancer
NHS Lothian
Pfizer
The Institute of Cancer Research
Last reviewed: 3 January 2018
CRUK internal database number: 424
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
